EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis
27 August 2021
ESC Premium Access
EMPEROR-Preserved - Discussant review.
27 August 2021
Open Access
Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?